PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
-13.7%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$9.35B
AUM Growth
-$2.4B
(-20%)
Cap. Flow
-$758M
Cap. Flow
% of AUM
-8.11%
Top 10 Holdings %
Top 10 Hldgs %
23.17%
Holding
296
New
31
Increased
109
Reduced
93
Closed
43
Top Buys
| 1 |
Danaher
DHR
|
$66.9M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$61M |
| 3 |
Thermo Fisher Scientific
TMO
|
$51.3M |
| 4 |
Boston Scientific
BSX
|
$44.2M |
| 5 |
Arista Networks
ANET
|
$43.1M |
Top Sells
| 1 |
Merck
MRK
|
$115M |
| 2 |
Amgen
AMGN
|
$102M |
| 3 |
Apple
AAPL
|
$82.8M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
$72.8M |
| 5 |
Flex
FLEX
|
$70.4M |
Sector Composition
| 1 | Technology | 25.49% |
| 2 | Financials | 23.49% |
| 3 | Healthcare | 21.31% |
| 4 | Communication Services | 7.67% |
| 5 | Consumer Discretionary | 6.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Sarepta Therapeutics
SRPT
$1.96B
| $21.9M | 0.23% |
200,482
+150,482
| +301% | +$16.4M |
|
|
STML
127
DELISTED
Stemline Therapeutics, Inc.
STML
| $21.9M | 0.23% |
2,302,666
+248,616
| +12% | +$2.36M |
|
128
Alnylam Pharmaceuticals
ALNY
$59.2B
| $21.5M | 0.23% |
294,287
+50,000
| +20% | +$3.65M |
|
129
RLI Corp
RLI
$6.16B
| $20.9M | 0.22% |
607,000
-10,000
| -2% | -$345K |
|
130
Vertex Pharmaceuticals
VRTX
$102B
| $20.7M | 0.22% |
125,000
-95,000
| -43% | -$15.7M |
|
|
ALTR
131
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $20.3M | 0.22% |
+735,844
| New | +$20.3M |
|
132
Texas Pacific Land
TPL
$20.4B
| $20.2M | 0.22% |
111,795
+25,851
| +30% | +$4.67M |
|
133
Affiliated Managers Group
AMG
$6.54B
| $20M | 0.21% |
205,490
+1,398
| +0.7% | +$136K |
|
|
134
Amgen
AMGN
$153B
| $19.7M | 0.21% |
101,075
-525,000
| -84% | -$102M |
|
|
LHCG
135
DELISTED
LHC Group LLC
LHCG
| $19.5M | 0.21% |
208,234
-61,924
| -23% | -$5.81M |
|
136
Universal Display
OLED
$6.91B
| $19.1M | 0.2% |
204,530
+5,390
| +3% | +$504K |
|
137
Aflac
AFL
$57.2B
| $19M | 0.2% |
417,000
-8,000
| -2% | -$364K |
|
138
Heritage Insurance Holdings
HRTG
$747M
| $18.8M | 0.2% |
1,278,500
-21,500
| -2% | -$316K |
|
139
Lumentum
LITE
$10.4B
| $18.8M | 0.2% |
447,464
+14,102
| +3% | +$592K |
|
140
Corning
GLW
$61B
| $18.6M | 0.2% |
617,284
-687,596
| -53% | -$20.8M |
|
|
MDC
141
DELISTED
M.D.C. Holdings, Inc.
MDC
| $18.6M | 0.2% |
773,336
-332,419
| -30% | -$8.01M |
|
142
CVS Health
CVS
$93.6B
| $18M | 0.19% |
+275,000
| New | +$18M |
|
|
CELG
143
DELISTED
Celgene Corp
CELG
| $17.6M | 0.19% |
275,000
-160,000
| -37% | -$10.3M |
|
144
IAC Inc
IAC
$2.98B
| $16.6M | 0.18% |
508,315
+44,478
| +10% | +$1.45M |
|
145
Agios Pharmaceuticals
AGIO
$2.09B
| $15.4M | 0.17% |
335,000
-267,342
| -44% | -$12.3M |
|
|
PVG
146
DELISTED
PRETIUM RESOURCES INC.
PVG
| $15.4M | 0.17% |
+1,826,630
| New | +$15.4M |
|
147
Biogen
BIIB
$20.6B
| $15M | 0.16% |
50,000
-25,000
| -33% | -$7.52M |
|
148
Gilead Sciences
GILD
$143B
| $14.1M | 0.15% |
225,000
+24,896
| +12% | +$1.56M |
|
149
Toronto Dominion Bank
TD
$127B
| $13.9M | 0.15% |
229,749
-3,681
| -2% | -$223K |
|
|
BNFT
150
DELISTED
Benefitfocus, Inc.
BNFT
| $13.9M | 0.15% |
303,854
+18,365
| +6% | +$840K |
|